• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测植入式皮下心脏除颤器的 Brugada 综合征患者不合理电击的因素。

Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.

机构信息

Cardiology Department, Ospedale San Francesco, Nuoro, Italy.

Biomedical Science PhD Course, University of Sassari, Sassari, Italy.

出版信息

J Cardiovasc Electrophysiol. 2021 Jun;32(6):1704-1711. doi: 10.1111/jce.15059. Epub 2021 May 5.

DOI:10.1111/jce.15059
PMID:33928706
Abstract

BACKGROUND

Subcutaneous implantable cardioverter defibrillators (S-ICDs) avoid complications secondary to transvenous leads, but inappropriate shocks (ISs) are frequent. Furthermore, IS data from patients with Brugada syndrome (BrS) with an S-ICD are scarce.

OBJECTIVE

We aimed to establish the frequency and predictors of IS in this population.

METHODS

We analyzed the clinical and electrocardiographic characteristics, automated screening test data, device programming, and IS occurrence in adult patients with BrS with an S-ICD.

RESULTS

Thirty-nine patients were enrolled (69% male, mean age at diagnosis 46 ± 13 years, mean age at implantation 48 ± 13 years). During a mean follow-up of 26 ± 21 months, 18% patients experienced IS. Patients with IS were younger at the time of diagnosis (36 ± 8 vs. 48 ± 13 years, p = .018) and S-ICD implantation (38 ± 9 vs. 50 ± 23 years, p = .019) and presented with spontaneous type 1 Brugada electrocardiogram pattern more frequently at diagnosis or during follow-up (71% vs. 25%, p = .018). During automated screening tests, patients with IS showed lower QRS voltage in the primary vector in the supine position (0.58 ± 0.26 vs. 1.10 ± 0.35 mV, p = .011) and lower defibrillator automated screening score in the primary vector in the supine (123 ± 165 vs. 554 ± 390 mV, p = .005) and standing (162 ± 179 vs. 486 ± 388 mV, p = .038) positions. Age at diagnosis was the only independent predictor of IS (hazard ratio = 0.873, 95% confidence interval: 0.767-0.992, p = .037).

CONCLUSION

IS was a frequent complication in patients with BrS with an S-ICD. Younger age was independently associated with IS. A more thorough screening process might help prevent IS in this population.

摘要

背景

皮下植入式心律转复除颤器(S-ICD)可避免经静脉导联引起的并发症,但不恰当电击(IS)较为常见。此外,S-ICD 用于 Brugada 综合征(BrS)患者时的 IS 数据十分有限。

目的

本研究旨在确定该人群中 IS 的发生频率和预测因素。

方法

我们分析了 S-ICD 植入的 BrS 成年患者的临床和心电图特征、自动筛查试验数据、设备编程和 IS 发生情况。

结果

共纳入 39 例患者(69%为男性,诊断时的平均年龄为 46±13 岁,植入时的平均年龄为 48±13 岁)。在平均 26±21 个月的随访期间,18%的患者发生了 IS。发生 IS 的患者诊断时年龄较小(36±8 岁 vs. 48±13 岁,p=0.018)和植入 S-ICD 时年龄较小(38±9 岁 vs. 50±23 岁,p=0.019),且更常出现自发性 1 型 Brugada 心电图模式(71% vs. 25%,p=0.018)。在自动筛查试验中,发生 IS 的患者在仰卧位时的主向量 QRS 电压较低(0.58±0.26 与 1.10±0.35 mV,p=0.011),仰卧位和站立位时的主向量自动筛查评分较低(123±165 与 554±390 mV,p=0.005;162±179 与 486±388 mV,p=0.038)。诊断时的年龄是 IS 的唯一独立预测因素(风险比=0.873,95%置信区间:0.767-0.992,p=0.037)。

结论

IS 是 BrS 患者植入 S-ICD 后的常见并发症。年龄较小与 IS 独立相关。更全面的筛查过程可能有助于预防该人群的 IS。

相似文献

1
Predictors of inappropriate shock in Brugada syndrome patients with a subcutaneous implantable cardiac defibrillator.预测植入式皮下心脏除颤器的 Brugada 综合征患者不合理电击的因素。
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1704-1711. doi: 10.1111/jce.15059. Epub 2021 May 5.
2
Usefulness of subcutaneous implantable cardioverter-defibrillator therapy in patients with Brugada syndrome.皮下植入式心脏复律除颤器治疗 Brugada 综合征患者的有效性。
Heart Vessels. 2021 Feb;36(2):260-266. doi: 10.1007/s00380-020-01683-0. Epub 2020 Aug 24.
3
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.药物诱导 1 型 ECG 图形 Brugada 综合征患者中皮下与经静脉植入式心脏复律除颤器的比较:来自 IBRYD 研究的倾向评分匹配分析。
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
4
Implantable Cardioverter-Defibrillators in Children and Adolescents With Brugada Syndrome.儿童和青少年 Brugada 综合征患者的植入式心脏复律除颤器。
J Am Coll Cardiol. 2018 Jan 16;71(2):148-157. doi: 10.1016/j.jacc.2017.10.082.
5
Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.Brugada 综合征患者植入心脏复律除颤器后的结局:一项多中心研究 - 第 2 部分。
Circulation. 2013 Oct 15;128(16):1739-47. doi: 10.1161/CIRCULATIONAHA.113.001941. Epub 2013 Aug 30.
6
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.SMART Pass 滤器对阿义马林诱导 Brugada 综合征和皮下植入式心脏复律除颤器植入失败患者的影响:前瞻性多中心研究结果。
Europace. 2022 May 3;24(5):845-854. doi: 10.1093/europace/euab230.
7
Lights and shadows of subcutaneous implantable cardioverter-defibrillator in Brugada syndrome.皮下植入式心律转复除颤器在布加综合征中的利弊
Heart Rhythm. 2023 Feb;20(2):274-281. doi: 10.1016/j.hrthm.2022.09.016. Epub 2022 Sep 24.
8
Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.Brugada 综合征:运动应激试验后皮下植入式心脏复律除颤器的适应证。
Rev Port Cardiol (Engl Ed). 2021 Jan;40(1):33-38. doi: 10.1016/j.repc.2020.05.013. Epub 2021 Jan 9.
9
Effect of diurnal variations in the QRS complex and T waves on the eligibility for subcutaneous implantable cardioverter-defibrillators.QRS 波群和 T 波的日间变化对皮下植入式心脏除颤器适应证的影响。
Heart Rhythm. 2019 Jun;16(6):913-920. doi: 10.1016/j.hrthm.2019.01.004. Epub 2019 Jan 4.
10
High rate of subcutaneous implantable cardioverter-defibrillator sensing screening failure in patients with Brugada syndrome: a comparison with other inherited primary arrhythmia syndromes.Brugada 综合征患者皮下植入式心律转复除颤器感知筛查失败率高:与其他遗传性原发性心律失常综合征的比较。
Europace. 2018 Jul 1;20(7):1188-1193. doi: 10.1093/europace/eux009.

引用本文的文献

1
Real-World Efficacy and Safety of the Subcutaneous Implantable Cardioverter Defibrillator: Insights from the GASP Registry.皮下植入式心律转复除颤器的真实世界疗效与安全性:来自GASP注册研究的见解
Biomedicines. 2025 Jun 20;13(7):1510. doi: 10.3390/biomedicines13071510.
2
Management of sensing issues with a subcutaneous implantable cardioverter-defibrillator in a patient with Brugada syndrome: A case report.布加综合征患者皮下植入式心律转复除颤器感知问题的管理:一例报告
HeartRhythm Case Rep. 2023 Sep 16;9(12):878-882. doi: 10.1016/j.hrcr.2023.09.009. eCollection 2023 Dec.
3
The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective.
皮下植入式心脏复律除颤器:患者视角
J Clin Med. 2023 Oct 22;12(20):6675. doi: 10.3390/jcm12206675.
4
Subcutaneous versus transvenous implantable cardioverter-defibrillator among drug-induced type-1 ECG pattern Brugada syndrome: a propensity score matching analysis from IBRYD study.药物诱导 1 型 ECG 图形 Brugada 综合征患者中皮下与经静脉植入式心脏复律除颤器的比较:来自 IBRYD 研究的倾向评分匹配分析。
Heart Vessels. 2023 May;38(5):680-688. doi: 10.1007/s00380-022-02204-x. Epub 2022 Nov 24.
5
Predictors of late arrhythmic events after generator replacement in Brugada syndrome treated with prophylactic ICD.植入预防性植入式心律转复除颤器(ICD)治疗的 Brugada 综合征患者,发生器更换术后晚期心律失常事件的预测因素。
Front Cardiovasc Med. 2022 Jul 22;9:964694. doi: 10.3389/fcvm.2022.964694. eCollection 2022.
6
Air entrapment as a potential cause of early subcutaneous implantable cardioverter defibrillator malfunction: a systematic review of the literature.空气栓塞作为早期皮下植入式心脏除颤器故障的潜在原因:文献系统回顾。
Europace. 2022 Oct 13;24(10):1608-1616. doi: 10.1093/europace/euac046.
7
Impact of SMART Pass filter in patients with ajmaline-induced Brugada syndrome and subcutaneous implantable cardioverter-defibrillator eligibility failure: results from a prospective multicentre study.SMART Pass 滤器对阿义马林诱导 Brugada 综合征和皮下植入式心脏复律除颤器植入失败患者的影响:前瞻性多中心研究结果。
Europace. 2022 May 3;24(5):845-854. doi: 10.1093/europace/euab230.